Real-world efficacy and safety of immunochemotherapy in cold agglutinin-mediated autoimmune haemolytic anaemia
Publication date
2025-12
Authors
Mulder, Femke V M
Becking, Anne-Marie L
Bernelot Moens, Sophie J
Jalink, Marit
Evers, Dorothea
te Boome, Liane C J
Breedijk, Anouk
Droogendijk, Jolanda
van der Griend, René
de Heer, Koen
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Keywords
autoimmune haemolytic anaemia, bendamustine, cold agglutinin disease, cyclophosphamide, lymphoproliferative, Hematology
Citation
Mulder, F V M, Becking, A-M L, Bernelot Moens, S J, Jalink, M, Evers, D, Te Boome, L, Breedijk, A, Droogendijk, J, van der Griend, R, de Heer, K, Mäkelburg, A B U, Mandigers, C M P W, Nieuwenhuizen, L, Oostvogels, R, Pruijt, J F M H, Regelink, J, Rozenberg, J, Strobbe, L, van der Valk, F M, Lissenberg-Witte, B I & Vos, J M I 2025, 'Real-world efficacy and safety of immunochemotherapy in cold agglutinin-mediated autoimmune haemolytic anaemia', British Journal of Haematology, vol. 207, no. 6, pp. 2653-2658. https://doi.org/10.1111/bjh.70215